시장보고서
상품코드
1429555

세계의 마이크로바이옴 시장 보고서(2024년)

Microbiome Global Market Report 2024

발행일: | 리서치사: The Business Research Company | 페이지 정보: 영문 250 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    


■ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

마이크로바이옴 시장 규모는 향후 몇 년동안 빠르게 성장할 것으로 예상됩니다. 2028년에는 16.0%의 연평균 복합 성장률(CAGR)로 12억 4,000만 달러 규모에 달할 것으로 예상됩니다. 예측 기간 동안 예상되는 성장은 의료비 증가, 개인 맞춤형 의료에 대한 수요 증가, 자금 증가, 기술 발전, 만성 질환의 유병률 증가에 기인할 수 있습니다. 예측 기간 동안 주요 동향으로는 향상된 분석 및 프로세스 최적화를 위한 인공지능의 사용, 제품 포트폴리오 확대, 수익 증가, 카테고리 리더십 확보를 위한 전략적 협업 및 계약 등이 있습니다. 또한, 보다 정확한 정보와 효율성 향상을 위한 3D 프린팅 기술에 대한 투자, 다양한 질병에 대한 마이크로바이옴 치료제를 개발하기 위한 파이프라인 연구 증가, 수익 극대화를 위한 종양학 마이크로바이옴 치료제 개발 모색, 그리고 나노 기술 검토에 중점을 둘 것으로 예상됩니다. 에 중점을 두고 있습니다. 소량의 샘플을 사용하여 사용되는 정밀 기술의 생산성, 효율성 및 정확성을 향상시킵니다.

마이크로바이옴 시장의 성장은 염증성 장 질환(IBD)의 유병률 증가에 의해 주도되고 있습니다. IBD는 소화관, 특히 위장관에 영향을 미치는 만성 염증성 질환군으로 구성됩니다. IBD에서 장내 미생물 군집의 역할에 대한 관심이 높아짐에 따라 미생물 군집 중심의 연구, 진단 및 치료가 촉진되어 시장 확장을 촉진했습니다. 예를 들어, Temple Health는 2021년 2월 현재 미국에서 160만 명 이상이 IBD를 앓고 있으며, 유병률은 계속 증가할 것으로 예상된다고 보고했습니다. 이에 따라 IBD 환자 급증은 마이크로바이옴 시장의 성장을 가속할 것으로 예상됩니다.

의료비 증가는 마이크로바이옴 시장의 성장을 더욱 촉진할 것으로 예상됩니다. 특정 의료 시스템 또는 경제 내에서 의료 서비스 및 관련 활동에 지출되는 총액을 포함한 의료 지출은 마이크로바이옴 시장을 촉진하는 데 중요한 역할을 할 것입니다. 마이크로바이옴 연구개발에 대한 투자 증가와 인체 건강에서 마이크로바이옴의 중요성에 대한 인식이 높아짐에 따라 마이크로바이옴 기반 치료법과 제품에 대한 수요가 증가하고 있습니다. 2023년 5월 국가통계국 보고서에 따르면 2020년에서 2021년 사이 영국의 의료비 지출은 명목상 9.4%, 실질 9.7% 증가했으며, 2021년 영국의 총 의료비 지출은 3,672억 5,000만 달러, 2021년 의약품 지출은 518억 4,000만 달러(396억 파운드)에 달했습니다.(396억 파운드), 예방 의료 지출은 459억 3,000만 달러(351억 파운드)로 2020년 대비 두 배 이상 증가했습니다. 이는 의료비 증가의 주요 요인으로 작용하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 거시경제 시나리오

  • 고인플레이션이 시장에 미치는 영향
  • 우크라이나·러시아 전쟁이 시장에 미치는 영향
  • 시장에 대한 COVID-19의 영향

제5장 세계 시장 규모와 성장

  • 세계의 마이크로바이옴 시장 성장 촉진요인과 억제요인
    • 시장 성장 촉진요인
    • 시장 성장 억제요인
  • 세계의 마이크로바이옴 시장 규모 실적과 성장, 2018-2023년
  • 세계의 마이크로바이옴 시장 규모와 성장 예측, 2023-2028년, 2033년

제6장 시장 세분화

  • 세계의 마이크로바이옴 시장, 유형별 세분화, 실적과 예측, 2018-2023년, 2023-2028년, 2033년
  • Fecal Microbiota Transplantation(FMT)
  • 마이크로바이옴 약물
  • 세계의 마이크로바이옴 시장, 제품별 세분화, 실적과 예측, 2018-2023년, 2023-2028년, 2033년
  • 치료
  • 진단
  • 세계의 마이크로바이옴 시장, 기술별 세분화, 실적과 예측, 2018-2023년, 2023-2028년, 2033년
  • 게노믹스
  • 프로테오믹스
  • 메타볼로믹스
  • 세계의 마이크로바이옴 시장, 용도별 세분화, 실적과 예측, 2018-2023년, 2023-2028년, 2033년
  • 염증성 장질환
  • 당뇨병
  • 다발성 경화증
  • 류마티스 관절염
  • 기타

제7장 지역 및 국가별 분석

  • 세계의 마이크로바이옴 시장, 지역별, 실적과 예측, 2018-2023년, 2023-2028년, 2033년
  • 세계의 마이크로바이옴 시장, 국가별, 실적과 예측, 2018-2023년, 2023-2028년, 2033년

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

  • 마이크로바이옴 시장 경쟁 구도
  • 마이크로바이옴 시장 기업 개요
    • Seres Therapeutics
    • Enterome Bioscience
    • Ferring Pharmaceuticals
    • Vedanta BioSciences
    • Second Genome Inc.

제31장 기타 주요 기업과 혁신 기업

  • Microbiotica
  • Rebiotix, Inc
  • Locus Biosciences
  • Osel Inc.
  • Xbiome Co., Ltd
  • Microba Life Sciences
  • Biome Australia
  • Shoreline Biome
  • Leucine Rich Bio Pvt Ltd
  • BugSpeaks
  • KINS Co., Ltd
  • Yeda Research and Development Co. Ltd
  • China National Pharmaceutical Group Corporation
  • Atlas Biomed
  • BiomX Ltd

제32장 경쟁 벤치마킹

제33장 경쟁 대시보드

제34장 주요 인수합병(M&A)

제35장 향후 전망과 잠재성 분석

제36장 부록

LSH 24.03.08

A microbiome refers to a community of microbes inhabiting a specific habitat, comprising fungi, bacteria, and viruses. It encompasses all the genetic material of bacteria, fungi, protozoa, and viruses that reside on and within the human body. The bacteria within the microbiome play crucial roles in digestion, immune system regulation, defense against disease-causing bacteria, and the production of essential vitamins such as Vitamin K, necessary for blood clotting, and B vitamins such as B12, thiamine, and riboflavin.

The primary types of microbiomes include bacteria, archaea, viruses, and other microorganisms. Bacteria, single-celled microorganisms belonging to the domain Bacteria, are diverse and abundant life forms found in various environments. Products associated with microbiomes include therapeutics and diagnostics, and technologies such as genomics, proteomics, and metabolomics are employed in conditions such as inflammatory bowel disease, gastrointestinal disorders, metabolic disorders, cancers, and other diseases.

The microbiome market research report is one of a series of new reports from The Business Research Company that provides microbiome market statistics, including microbiome industry global market size, regional shares, competitors with a microbiome market share, detailed microbiome market segments, market trends, and opportunities, and any further data you may need to thrive in the microbiome industry. This microbiome market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The microbiome market size has grown exponentially in recent years. It will grow from $0.57 billion in 2023 to $0.69 billion in 2024 at a compound annual growth rate (CAGR) of 20.2%. The growth observed in the historical period can be attributed to an increased demand for immunology, rising collaborations, government initiatives, increased healthcare expenditure, and growth in the number of healthcare facilities.

The microbiome market size is expected to see rapid growth in the next few years. It will grow to $1.24 billion in 2028 at a compound annual growth rate (CAGR) of 16.0%. The anticipated growth in the forecast period can be attributed to a rise in healthcare expenditure, an increasing demand for personalized medicine, growing funding, technological advances, and the rising prevalence of chronic diseases. Key trends in the forecast period include the use of artificial intelligence for enhanced analysis and process optimization, strategic collaborations and agreements to expand product portfolios, boost revenues, and establish category leadership. Additionally, there is an emphasis on investing in 3D printing technology for more accurate information and increased efficiency, increasing the number of pipeline studies to develop microbiome therapeutics for various diseases, exploring the development of oncology microbiome therapeutics to maximize revenues, and considering nanotechnology for identifying low-abundant samples to enhance the productivity, efficiency, and accuracy of precision technologies in use.

The growth of the microbiome market is being propelled by the increasing prevalence of inflammatory bowel disease (IBD). IBD comprises a group of chronic inflammatory disorders affecting the digestive tract, particularly the gastrointestinal (GI) tract. The heightened focus on the gut microbiome's role in IBD has spurred research, diagnostics, and therapies centered on the microbiome, fostering the market's expansion. For example, as of February 2021, Temple Health reported that over 1.6 million individuals in the United States are living with IBD, with expectations of a continued increase in prevalence. Consequently, the surge in IBD cases is anticipated to drive the growth of the microbiome market.

The rise in healthcare expenditure is poised to further propel the microbiome market's growth. Healthcare expenditure, encompassing the total amount spent on healthcare services and related activities within a specific healthcare system or economy, plays a crucial role in boosting the microbiome market. Increased investments in microbiome research and development, coupled with growing awareness of the microbiome's significance in human health, are driving the demand for microbiome-based therapies and products. As of May 2023, a report from the Office for National Statistics revealed that healthcare spending in the UK witnessed a 9.4% nominal and 9.7% real-term increase between 2020 and 2021. The total healthcare expenditure in the UK for 2021 amounted to $367.25 billion (£280.7 billion), with pharmaceutical expenditure at $51.84 billion (£39.6 billion) and spending on preventive care at $45.93 billion (£35.1 billion) in 2021, more than doubling from 2020. Thus, escalating healthcare expenditures are a key driver of the microbiome market's growth.

Technological improvement is emerging as a significant trend in the microbiome market. Major companies in the microbiome sector are actively developing advanced technological solutions, such as Seed's introduction of the Probiotic and Prebiotic Daily Synbiotic for both females and males. Seed's Daily Synbiotic adopts a microbe-system strategy, providing strain-specific benefits beyond digestive health, including cardiac safety, dermatological health, immune control, reproductive health, gut barrier integrity, and oxidative stress.

Strategic partnerships are a notable approach employed by major companies in the microbiome market for their growth and development strategies. These partnerships involve leveraging each other's strengths and resources to achieve mutual benefits. For instance, in June 2021, Illumina Inc., a US-based biotechnology company, formed a partnership with Microba Life Sciences Ltd., an Australia-based precision microbiome company. The collaboration aims to combine expertise in next-generation sequencing (NGS) and gut microbiome analysis to enhance data accuracy and comprehensiveness, make microbiome research more accessible in the Asia Pacific and Japan regions, and expedite the development of microbiome-based therapies and diagnostics.

In January 2021, Novozymes, a Denmark-based biotechnology company, acquired Microbiome Labs for an undisclosed amount. This acquisition is a strategic move to expand Novozymes' Human Health platform, providing access to a range of patented solutions and a network of health professionals. Microbiome Labs, a probiotics company, is based in the United States.

Major companies operating in the microbiome market report are Seres Therapeutics, Enterome Bioscience, Ferring Pharmaceuticals, Vedanta BioSciences, Second Genome Inc., Microbiotica, Rebiotix, Inc., Locus Biosciences, Osel Inc., Xbiome Co., Ltd., Microba Life Sciences, Biome Australia, Shoreline Biome, Leucine Rich Bio Pvt Ltd., BugSpeaks, KINS Co., Ltd., Yeda Research and Development Co. Ltd., China National Pharmaceutical Group Corporation, Atlas Biomed, BiomX Ltd., ImmuneBiotech Medical Sweden AB, MetaboGen AB, ADM Biopolis, Viome, PharmaBiome, NCCR Microbiomes, MaaT Pharma, Eligo Bioscience, T3 Pharmaceuticals, MicroBiome Therapeutics LLC, Second Genome, OpenBiome, Microbiome Insights Inc., lallemand Health Solutions, Mybiotics Pharma, DayTwo, Next Biosciences, ViThera Pharmaceuticals Inc., Inqaba Biotechnical Industries (Pty), SNIPR Biome, MyBiome

North America was the largest region in the microbiome market in 2023. The regions covered in the microbiome market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the microbiome market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The microbiome market consists of sales of firmicutes, bacteroidetes, and actinobacteria. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Microbiome Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on microbiome market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for microbiome? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The microbiome market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Type: Bacteria; Archaea; Viruses; Other Microbiomes
  • 2) By Product: Therapeutics; Diagnostics
  • 4) By Technology: Genomics; Proteomics; Metabolomics
  • 3) By End-Use: Infectious Diseases; Gastrointestinal Disorders; Metabolic Disorders; Cancers; Other Diseases
  • Sub segments: Infectious Diseases; Gastrointestinal Disorders; Metabolic Disorders; Cancers; Others; Genomics; Proteomics; Metabolomics
  • Companies Mentioned: Seres Therapeutics; Enterome Bioscience; Ferring Pharmaceuticals; Vedanta BioSciences; Second Genome Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Microbiome Market Characteristics

3. Microbiome Market Trends And Strategies

4. Microbiome Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Microbiome Market Size and Growth

  • 5.1. Global Microbiome Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Microbiome Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Microbiome Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Microbiome Market Segmentation

  • 6.1. Global Microbiome Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Fecal Microbiota Transplantation (FMT)
  • Microbiome drugs
  • 6.2. Global Microbiome Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Therapeutics
  • Diagnostics
  • 6.3. Global Microbiome Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Genomics
  • Proteomics
  • Metabolomics
  • 6.4. Global Microbiome Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Inflammatory Bowel Disease
  • Diabetes
  • Multiple Sclerosis
  • Rheumatoid Arthritis
  • Other Applications

7. Microbiome Market Regional And Country Analysis

  • 7.1. Global Microbiome Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Microbiome Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Microbiome Market

  • 8.1. Asia-Pacific Microbiome Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Microbiome Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Microbiome Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Microbiome Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Microbiome Market

  • 9.1. China Microbiome Market Overview
  • 9.2. China Microbiome Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Microbiome Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Microbiome Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Microbiome Market

  • 10.1. India Microbiome Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Microbiome Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Microbiome Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Microbiome Market

  • 11.1. Japan Microbiome Market Overview
  • 11.2. Japan Microbiome Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Microbiome Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Microbiome Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Microbiome Market

  • 12.1. Australia Microbiome Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Microbiome Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Microbiome Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Microbiome Market

  • 13.1. Indonesia Microbiome Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Microbiome Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Microbiome Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Microbiome Market

  • 14.1. South Korea Microbiome Market Overview
  • 14.2. South Korea Microbiome Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Microbiome Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Microbiome Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Microbiome Market

  • 15.1. Western Europe Microbiome Market Overview
  • 15.2. Western Europe Microbiome Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Microbiome Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Microbiome Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Microbiome Market

  • 16.1. UK Microbiome Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Microbiome Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Microbiome Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Microbiome Market

  • 17.1. Germany Microbiome Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Microbiome Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Microbiome Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Microbiome Market

  • 18.1. France Microbiome Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Microbiome Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Microbiome Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Microbiome Market

  • 19.1. Italy Microbiome Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Microbiome Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Microbiome Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Microbiome Market

  • 20.1. Spain Microbiome Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Microbiome Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Microbiome Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Microbiome Market

  • 21.1. Eastern Europe Microbiome Market Overview
  • 21.2. Eastern Europe Microbiome Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Microbiome Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Microbiome Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Microbiome Market

  • 22.1. Russia Microbiome Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Microbiome Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Microbiome Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Microbiome Market

  • 23.1. North America Microbiome Market Overview
  • 23.2. North America Microbiome Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Microbiome Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Microbiome Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Microbiome Market

  • 24.1. USA Microbiome Market Overview
  • 24.2. USA Microbiome Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Microbiome Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Microbiome Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Microbiome Market

  • 25.1. Canada Microbiome Market Overview
  • 25.2. Canada Microbiome Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Microbiome Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Microbiome Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Microbiome Market

  • 26.1. South America Microbiome Market Overview
  • 26.2. South America Microbiome Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Microbiome Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Microbiome Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Microbiome Market

  • 27.1. Brazil Microbiome Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Microbiome Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Microbiome Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Microbiome Market

  • 28.1. Middle East Microbiome Market Overview
  • 28.2. Middle East Microbiome Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Microbiome Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Microbiome Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Microbiome Market

  • 29.1. Africa Microbiome Market Overview
  • 29.2. Africa Microbiome Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Microbiome Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Microbiome Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Microbiome Market Competitive Landscape And Company Profiles

  • 30.1. Microbiome Market Competitive Landscape
  • 30.2. Microbiome Market Company Profiles
    • 30.2.1. Seres Therapeutics
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Enterome Bioscience
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Ferring Pharmaceuticals
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Vedanta BioSciences
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Second Genome Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Microbiome Market Other Major And Innovative Companies

  • 31.1. Microbiotica
  • 31.2. Rebiotix, Inc
  • 31.3. Locus Biosciences
  • 31.4. Osel Inc.
  • 31.5. Xbiome Co., Ltd
  • 31.6. Microba Life Sciences
  • 31.7. Biome Australia
  • 31.8. Shoreline Biome
  • 31.9. Leucine Rich Bio Pvt Ltd
  • 31.10. BugSpeaks
  • 31.11. KINS Co., Ltd
  • 31.12. Yeda Research and Development Co. Ltd
  • 31.13. China National Pharmaceutical Group Corporation
  • 31.14. Atlas Biomed
  • 31.15. BiomX Ltd

32. Global Microbiome Market Competitive Benchmarking

33. Global Microbiome Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Microbiome Market

35. Microbiome Market Future Outlook and Potential Analysis

  • 35.1 Microbiome Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Microbiome Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Microbiome Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제